Shannon Stapleton | Reuters
The drugstore chain reported fiscal fourth-quarter net income of $975 million, or 75 cents per share, down from $1.74 billion, or $1.33 per share, a year earlier. Revenue rose to $69.55 billion, from $66.89 billion a year prior. That's higher than analysts' expectations of $68.75 billion, according to Refinitiv.
لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر:
CV, covid ? upload them on linkedin, it's a Microsoff company
$CLOV LFG.
$CLOV LfG